Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis
- PMID: 16835467
- DOI: 10.5551/jat.13.130
Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis
Abstract
Vascular endothelial growth factor (VEGF)-A plays a critical role in vascular development and angiogenesis through its binding and activation of VEGF receptor-2 (VEGFR-2). The binding of VEGF-A to VEGFR-2 causes receptor dimerization, kinase activation and autophosphorylation of specific tyrosine residues within the dimeric complex. Tyrosine(Y)951 in the kinase-insert domain, Y1054 and Y1059 in the kinase domain and Y1175 and Y1214 in the C-terminal tail have been shown to serve as autophosphorylation sites. Phosphorylated Y1175 creates a binding site for phospholipase Cgamma1 (PLC-gamma1) and Shb. Activation of PLC-gamma1 and Shb regulates VEGF-A-dependent cell proliferation and cell migration, respectively. Phosphorylated Y951 binds and mediates tyrosine phosphorylation of the T-cell-specific adaptor protein (TSAd), which is expressed in endothelial cells. Y951-mediated coupling of VEGFR-2 and TSAd is critical for VEGF-A-induced cell migration and actin reorganization, and for pathological angiogenesis. These phosphorylation sites may be useful targets for the development of anti-angiogenic therapies to treat atherosclerosis and cancer.
Similar articles
-
VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis.EMBO J. 2005 Jul 6;24(13):2342-53. doi: 10.1038/sj.emboj.7600709. Epub 2005 Jun 16. EMBO J. 2005. PMID: 15962004 Free PMC article.
-
A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells.EMBO J. 2001 Jun 1;20(11):2768-78. doi: 10.1093/emboj/20.11.2768. EMBO J. 2001. PMID: 11387210 Free PMC article.
-
Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization.Oncogene. 1999 Feb 25;18(8):1619-27. doi: 10.1038/sj.onc.1202478. Oncogene. 1999. PMID: 10102632
-
Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis.Rom J Morphol Embryol. 2018;59(2):455-467. Rom J Morphol Embryol. 2018. PMID: 30173249 Review.
-
The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.Clin Sci (Lond). 2005 Sep;109(3):227-41. doi: 10.1042/CS20040370. Clin Sci (Lond). 2005. PMID: 16104843 Review.
Cited by
-
A novel angiogenesis inhibitor impairs lovo cell survival via targeting against human VEGFR and its signaling pathway of phosphorylation.Cell Death Dis. 2012 Oct 11;3(10):e406. doi: 10.1038/cddis.2012.145. Cell Death Dis. 2012. PMID: 23059825 Free PMC article.
-
The molecular pathogenesis of osteosarcoma: a review.Sarcoma. 2011;2011:959248. doi: 10.1155/2011/959248. Epub 2011 Apr 13. Sarcoma. 2011. PMID: 21559216 Free PMC article.
-
Gene expression of vascular endothelial growth factor A and hypoxic adaptation in Tibetan pig.J Anim Sci Biotechnol. 2016 Apr 2;7:21. doi: 10.1186/s40104-016-0082-z. eCollection 2016. J Anim Sci Biotechnol. 2016. PMID: 27042296 Free PMC article.
-
Next-Generation Sequencing in the Assessment of the Transcriptomic Landscape of DNA Damage Repair Genes in Abdominal Aortic Aneurysm, Chronic Venous Disease and Lower Extremity Artery Disease.Int J Mol Sci. 2022 Dec 29;24(1):551. doi: 10.3390/ijms24010551. Int J Mol Sci. 2022. PMID: 36614026 Free PMC article.
-
Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells.FASEB J. 2009 Nov;23(11):3865-73. doi: 10.1096/fj.09-134882. Epub 2009 Jul 22. FASEB J. 2009. PMID: 19625659 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases